Cediel, Eva <br/><br/>
AT-1 receptor antagonism modifies the mediation of endothelin-1, thromboxane A2, and catecholamines in the renal constrictor response to angiotensin II.  [electronic resource] 

 -  Kidney international. Supplement  Jan 2005 
 - S3-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0098-6577 
<br/><br/><label>Standard No.: </label>10.1111/j.1523-1755.2005.09302.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic alpha-Antagonists--pharmacology<br/>Angiotensin II--antagonists & inhibitors<br/>Angiotensin II Type 1 Receptor Blockers<br/>Animals<br/>Antihypertensive Agents--pharmacology<br/>Biphenyl Compounds--pharmacology<br/>Catecholamines--antagonists & inhibitors<br/>Dose-Response Relationship, Drug<br/>Endothelin-1--antagonists & inhibitors<br/>Irbesartan<br/>Male<br/>Potassium Chloride--pharmacology<br/>Prazosin--pharmacology<br/>Rats<br/>Rats, Inbred SHR<br/>Rats, Inbred WKY<br/>Receptor, Angiotensin, Type 1--drug effects<br/>Renal Circulation--drug effects<br/>Tetrazoles--pharmacology<br/>Thromboxane A2--antagonists & inhibitors<br/>Vasoconstrictor Agents--antagonists & inhibitors